F
$ Value
$217K
Shares
35,977
Price
$6
Filed
Feb 27
Insider
Name
Charhon Jean-Jacques
Title
EVP, CFO
CIK
0001725564
Roles
Officer
Transaction Details
Transaction Date
2026-02-26
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
755,538
Footnotes
Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. | This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
Filing Info
Charhon Jean-Jacques's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-27 | BHC | F | $291K |
| 2026-02-26 | BHC | F | $217K |
| 2026-02-25 | BHC | A | $0 |
Other Insiders at BHC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| LEUNG SANDRA | — | — | 2026-03-31 |
| Paulson John | — | — | 2026-03-31 |
| WECHSLER AMY B | — | — | 2026-03-31 |
|
APPIO THOMAS
Chief Executive Officer
|
— | — | 2026-03-02 |
|
Charhon Jean-Jacques
EVP, CFO
|
— | — | 2026-02-27 |
|
LEE STEVEN HYOSIG
SVP, Controller & CAO
|
— | — | 2026-02-25 |
|
Carson Seana
EVP, General Counsel
|
— | $115K | 2026-03-03 |
|
Lenar Aimee J.
EVP, US Pharma
|
— | — | 2026-02-26 |